ARDMORE, Okla., July 2 (AScribe Newswire) -- The Samuel Roberts Noble Foundation, Inc., is pleased to announce the formation of a multi-year relationship with Amaethon Limited, a UK-based technology commercialization business.
Under the terms of the agreement, Amaethon has the exclusive right to create value from the research and intellectual property (IP) generated from the Foundation's molecular plant biology research programs and projects. Amaethon will be responsible for identifying and facilitating license opportunities and identifying and working with the Foundation to form new spin-outs, including sourcing seed capital. In exchange for these services, Amaethon will receive a share of licensing income received by the Foundation and an equity position in spin-outs created from its research or intellectual property.
As the Foundation retains ownership in its intellectual property portfolio, it will execute all agreements required under the commercialization events secured.
"This relationship provides the Foundation with a greater ability to identify both U.S.-based and international licensees for its plant-related discoveries and innovations, as well as develop spin-out opportunities for these technologies," said Michael A. Cawley, Noble Foundation president. "We look forward to a long relationship with Amaethon and expect great successes in this endeavor."
"This is our second strategic IP-based relationship, and I am delighted to be working with another group of world-class scientists and researchers. The Noble Foundation has committed substantial resources, over a considerable time period, towards its scientific goals and this has culminated in many significant scientific advances," said Dr. Graham P. Howe, chief executive officer of Amaethon. "We look forward to working with the Foundation on the commercialization of the current and extensive IP portfolio and creating further high-quality commercial horizons."
###
About the Noble Foundation
The not-for-profit Noble Foundation operates in part to enhance agricultural resource management and plant productivity through consultation, demonstration, applied biotechnology and fundamental research.
The Foundation conducts its operations through three divisions: Plant Biology, Forage Improvement and Agricultural. The Plant Biology Division conducts biochemical, genetic and genomic research for crop improvement, enhancement of human and animal health and production of novel products in crops.
The Forage Improvement Division is developing new forage cultivars for the southern Great Plains, as well as other regions of the world, through conventional plant breeding and the application of biotechnology. The Agricultural Division educates and consults with regional farmers and ranchers to advance agricultural operations in southern Oklahoma and north Texas.
The Foundation's conducts research at its campus in Ardmore, Okla., and on more than 15,000 acres in southern Oklahoma. It employs more than 280 people from 16 countries.
Its scientists serve on the editorial boards of nine international journals, and the 14 principal investigators of the Plant Biology and Forage Improvement divisions collectively hold more than ten adjunct professor positions at United States universities, including Oklahoma State University, Rice University, University of Georgia, University of Oklahoma, University of Texas, Texas A&M University and Washington State University, as well as the University of York, York, UK.
In 2003, Noble scientists published more than 100 articles in peer-reviewed journals, including Nature, Science, Proceedings of the National Academy of Sciences USA, Plant Cell, Plant Journal and Crop Science.
For more information, contact Caroline Lara, communications specialist, at 580-224-6379.
###
About Amaethon Limited
Amaethon was established in 2003 as an innovative partnership between the University of York and IP2IPO Group plc and was created to commercialize the research of the Centre for Novel Agricultural Products, the flagship plant and microbial gene discovery research center based in the University of York, York, UK.
Amaethon operates as an entirely stand-alone business securing licenses, identifying and creating new companies, and capturing and managing industry sponsored research contracts. It is based in the Biosciences Building on the York Science Park, England.
Amaethon's objective is to become a world leading technology commercialization company in the field of gene discovery research targeted and the development of economically viable plant and microbial cell factories.
CONTACT INFORMATION
For further information contact Dr. Graham P. Howe, CEO, at + 44 (0-1904 567612.
Caroline Booth Lara, Communications Specialist;
580-224-6379, cblara@noble.org
|
|
|
AScribe Newswire distributes news from nonprofit and public sector organizations. We provide direct, immediate access to mainstream national media for 600 colleges, universities, medical centers, public-policy groups and other leading nonprofit organizations.
AScribe transmits news releases directly to newsroom computer systems and desktops of major media organizations via a supremely trusted channel - The Associated Press. We also feed news to major news retrieval database services, online publications and to developers of web sites and Intranets.
And AScribe does it at a cost all organizations, large and small, can afford, a fraction of what corporate newswires charge. Click here to see how we do it